Sponsor or institution
Clinical trials and research at Aqualung Therapeutics Corp.
As of November 12, 2026, Find a Trial lists 3 NIH-funded research projects at this institution, with $2.7 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 3NIH research projects
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Developing a new treatment for pulmonary hypertension
This study is testing a new treatment for pulmonary arterial hypertension (PAH) that uses a special antibody to block a protein linked to heart and lung problems, with the hope of helping patients feel better and live longer.
-
Testing a new therapy to reduce severe lung injury in patients with Acute Respiratory Distress Syndrome.
This study is testing a new treatment for Acute Respiratory Distress Syndrome (ARDS) using a special antibody called ALT-100 mAb, which aims to help reduce lung inflammation and improve recovery for patients with this condition.
-
Targeting a specific protein to reduce inflammation in bowel disease
This study is testing a new treatment called ALT-100, which is designed to help people with inflammatory bowel disease (IBD) by targeting a protein that makes inflammation worse, with the hope of reducing symptoms and improving bowel health.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.